Trial Profile
A phase 1 trial of fosbretabulin in patients with gastrointestinal neuroendocrine tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Gastrointestinal cancer; Neuroendocrine tumours
- Focus Therapeutic Use
- 06 Aug 2015 New trial record